Vickie Reed
Director/Board Member bij EVOKE PHARMA, INC.
Vermogen: - $ op 29-02-2024
Profiel
Op dit moment bekleedt Vickie S. Reed de functie van Chief Financial & Accounting Officer bij Mirati Therapeutics, Inc. Zij zit ook in de raad van bestuur van Evoke Pharma, Inc. Mevrouw Reed behaalde een bachelordiploma aan de Universiteit van Colorado.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
EVOKE PHARMA, INC.
-.--% | 10-05-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Vickie Reed
Bedrijven | Functie | Begin |
---|---|---|
EVOKE PHARMA, INC. | Director/Board Member | 13-05-2021 |
DMK PHARMACEUTICALS CORPORATION | Director/Board Member | 24-05-2022 |
Eerdere bekende functies van Vickie Reed
Bedrijven | Functie | Einde |
---|---|---|
MIRATI THERAPEUTICS | Director of Finance/CFO | 16-05-2022 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
ZOGENIX, INC. | Director of Finance/CFO | - |
Opleiding van Vickie Reed
The University of Colorado | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
EVOKE PHARMA, INC. | Health Technology |
DMK PHARMACEUTICALS CORPORATION | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |